Charles G Eberhart
Overview
Explore the profile of Charles G Eberhart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
372
Citations
17172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
August A, Cernichiaro-Espinosa L, Moctezuma-Davila M, Wibbelsman T, Wilson M, Chevez-Barrios P, et al.
Semin Ophthalmol
. 2025 Jan;
1-11.
PMID: 39869033
Objective: Ciliary body medulloepithelioma (CBME), a pediatric intraocular tumor with potential for locally aggressive behavior and metastasis, may present with a diverse spectrum of clinical and histopathologic features leading to...
2.
Tang V, Zhang K, Mirchia K, Lu R, Guney E, Terry M, et al.
Am J Surg Pathol
. 2025 Jan;
PMID: 39807609
Low-grade gliomas and reactive piloid gliosis can present with overlapping features on conventional histology. Given the large implications for patient treatment, there is a need for effective methods to discriminate...
3.
Geethadevi A, Vaidya N, Fisher R, Findlay T, Deng Y, Pham K, et al.
bioRxiv
. 2025 Jan;
PMID: 39763800
Background: Atypical teratoid rhabdoid tumor (ATRT) is the most common malignant brain tumor in infants, and more than 60% of children with ATRT die from their tumor. ATRT is associated...
4.
Lee S, Peterson C, Wang K, Alaali L, Eshleman J, Mahoney N, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337668
Ocular adnexal sebaceous carcinoma (SebCA) represents one of the most clinically problematic periocular tumors, often requiring aggressive surgical resection. The pathobiology of this tumor remains poorly understood, and few models...
5.
Joshi K, Yuan M, Katsushima K, Saulnier O, Ray A, Amankwah E, et al.
Res Sq
. 2024 Sep;
PMID: 39281885
Medulloblastoma, the most common malignant pediatric brain tumor, is classified into four main molecular subgroups, but group 3 and group 4 tumors are difficult to subclassify and have a poor...
6.
Joshi K, Yuan M, Katsushima K, Saulnier O, Ray A, Amankwah E, et al.
Acta Neuropathol Commun
. 2024 Aug;
12(1):138.
PMID: 39198884
Medulloblastoma, the most common malignant pediatric brain tumor, is classified into four main molecular subgroups, but group 3 and group 4 tumors are difficult to subclassify and have a poor...
7.
Kwak G, Grewal A, Slika H, Mess G, Li H, Kwatra M, et al.
ACS Nano
. 2024 Aug;
18(35):24139-24153.
PMID: 39172436
We introduce a two-pronged strategy comprising focused ultrasound (FUS)-mediated blood-brain barrier (BBB) opening and long-circulating biodegradable nanoparticles (NPs) for systemic delivery of nucleic acids to the brain. Biodegradable poly(β-amino ester)...
8.
Zhang K, Parker M, Weber-Levine C, Kalluri A, Gonzalez-Gomez I, Raabe E, et al.
Acta Neuropathol
. 2024 Aug;
148(1):19.
PMID: 39141113
No abstract available.
9.
Munoz Perez N, Pensabene J, Galbo Jr P, Sadeghipour N, Xiu J, Moziak K, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123357
Background: Relapsed medulloblastoma (MB) poses a significant therapeutic challenge due to its highly immunosuppressive tumor microenvironment. Immune checkpoint inhibitors (ICIs) have struggled to mitigate this challenge, largely due to low...
10.
Taga A, Wali A, Eberhart C, Green K
Neurology
. 2024 Jul;
103(4):e209707.
PMID: 39074341
No abstract available.